CDY11P

Across TCGA pan-cancer cohorts, CDY11P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated CDY11P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher CDY11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDY11P expression acts as an unfavorable survival marker.

ACC, STAD, and LUSC are the cancer types where CDY11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
STAD	OS	Tertile	All	0.142	0.730	<.001	45	view →
LUSC	OS	Tertile	All	0.346	0.732	.009	36	view →
KIRP	OS	Tertile	All	0.599	0.903	.001	36	view →
KIRC	OS	Tertile	All	0.286	0.631	.030	24	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CDY11P–ACC (DFS)

Open the ACC breakdown →